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ABSTRACT
Objective: The present study was conducted to investigate the role of Haematococcus pluvialis extract against oxidative damage, the inflammatory, 
and apoptotic impacts characterizing the neurodegenerative disorders.
Methods: Oxidative stress, B-cell lymphoma 2, brain-derived neurotrophic factor, the inflammation, apoptotic and antiapoptotic impacts in Alzheimer’s 
disease (AD) rats were determined through assessment of glutathione reduced (GSH), GSH peroxidase (GPx), lipid peroxide (malondialdehyde), the 
cytokines level such as tumor necrosis factor-alpha (TNF-α), interleukins (IL-6 and IL-1β), and macrophage inflammation protein (MIP1α) in AD rats. 
Moreover, the expression of phosphoinositide 3-kinase (PI3K) and serine-threonine protein kinase (Akt) genes regulating the apoptosis in AD rats 
was measured.
Results: The results revealed that levels of TNF-α, IL-6, IL-1β, and MIP1α were significantly increased in AD rats. Moreover, the expression of PI3K 
and Akt genes was downregulated which it was coincided with the increase of apoptosis in AD rats. On the other hand, treatment of AD rats with 
H. pluvialis extract decreased the oxidative stress of AD in the form of prevention the inflammatory and apoptotic impacts.
Conclusion: H. pluvialis could be used for ameliorating AD due to its role in decreases the oxidative stress of AD in the form of prevention the 
inflammatory and apoptotic impacts. H. pluvialis is a very attractive candidate for uses against neurodegenerative disorders that are caused by 
increases oxidative stress inducing neuroinflammation and apoptosis.
Keywords: Haematococcus pluvialis, Oxidative stress, Inflammation biomarkers, Apoptotic and antiapoptotic impacts.
INTRODUCTION
It is well known that oxidative damage affects the central nervous 
system (CNS) and is significantly assumed to induct Alzheimer’s 
pathogenesis [1]. The reasons of occurrence of these diseases because 
the brain of human is the target organ for the oxidative stress due to 
the following: (a) Increasing the oxygen utilization and enhancing 
the activity of the mitochondria in the nerve cells induces oxygen 
and nitrogen reactive species; (b) promoting the production of 
polyunsaturated fatty acids in the neural cells which are sensitive to 
oxidation; (c) increasing the reactive iron ions in several parts of the 
brain; (d) several neurotransmitters inter a cycle of auto-oxidation 
to produce neurotoxic components in the most of brain spaces [2]. 
Moreover, it has been found that oxidative stress in neural cells-induced 
inflammation is considered as one of the most reasons to induce CNS 
diseases [3-5]. One of the main reasons of inducing oxidative stress in 
neural cells is Alzheimer as showed in several experiments on animal 
models and human patients [5].
Several experiments on the neurotrophic factor derived in the 
brain revealed that brain-derived neurotrophic factor (BDNF) is 
overexpressed in several regions of the brain such as hippocampus and 
cortex. Moreover, BDNF is the main neuromolecule in the brain, which 
acts an important role in the survival and differentiation of the neural 
cells [6,7]. Furthermore, several studies were conducted on the BDNF-
mutant mice which exhibited increase in the impairment rate of memory 
behavior and learning [8,9]. Furthermore, it has been found that BDNF 
was able to decline the apoptosis rate in several brain regions, which is 
associated with enhancement the survival of neural cells without the 
presence of growth promoters [10]. In contrary, absence or decrease 
the level of BDNF is associated with increase the rate of apoptosis in the 
brain tissues. Moreover, increase the level of BDNF mRNA is coincided 
with increase the B-cell lymphoma 2 (Bcl-2) protein levels which are 
considered as antiapoptotic and protective protein for neural cells [10].
Recent research on Alzheimer demonstrated that occurring oxidative 
stress in the mitochondria is associated with high incidence of 
Alzheimer’s disease (AD) [11]. There are several pathways are 
responsible for the survival of the cells and act an important role in 
the induction of the oxidation stress in AD [12]. It has been found that 
phosphoinositide 3-kinase (PI3K)/Akt pathway is one of the most 
important pathways in this fact. The research on the PI3K/Akt pathway 
revealed that increase the concentration of amyloid beta protein in the 
brain cells of AD might be suppressing the PI3K/Akt pathway through 
decrease the PI3K and Akt activities [13,14]. Moreover, Akt in normal 
case is highly expressed in the brain cells and act as regulator of PI3K. 
In the same time, Akt is acting in several cases as enhancer for increase 
the phosphorylation in neural cells inducing apoptosis [15-17]. The 
apoptotic pathway by Akt signaling is attributed to regulation the 
expression of apoptotic-related genes such as Bcl-2 [18-20].
On the other hand, astaxanthin (ASTA) (3,3′-dihydroxy-β-β′-carotene-
4,4′-dione) presents in the natural extract from H. pluvialis which 
considered a powerful antioxidant and a good candidate for the 
prevention of intracellular oxidative stress. Antioxidant molecules, 
especially carotenoids, play an important role in controlling oxidative 
process. These antioxidant molecules (carotenoids) possess a strong 
antioxidant power due to their double-bonded structure, allowing the 
delocalization of impaired electrons [21]. There is a growing interest 
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in from the carotenoids’ family. It is a xanthophyll, meaning that, 
unlike β-carotene and lycopene, it is a polar molecule that is able to 
scavenge free oxygen radicals. The polyene chain in ASTA crosses the 
cell membrane, allowing the polar ends of the molecule to be exposed 
to the cytoplasm and external sides of the cell in the meantime [22,23]. 
This disposition facilitates the electron transfer from the cytoplasm to 
the outer part of the cell. The terminal ring of the ASTA seems to be the 
final scavenger of the reactive oxygen species (ROS). The ASTA by its 
provision could also have a synergistic effect with vitamin C that would 
recharge ASTA once it has scavenged ROS [24].
Therefore, the objective of this study was to investigate the impact of 
H. pluvialis extract against oxidative stress inducing inflammation. 
Moreover, the effect of H. pluvialis extract on the biological pathway 
regulating the apoptosis in AD rats was also studied.
MATERIALS AND METHODS
Chemicals
Donepezil, reagents, and kits were purchased from the Sigma Chemical 
Company (USA), whereas aluminum chloride (AlCl3) was purchased 
from CDH, India. TRIzol reagent was bought from Invitrogen (Germany). 
The reverse transcription and polymerase chain reaction (PCR) kits 
were obtained from Fermentas (USA). SYBR Green Mix was purchased 
from Stratagene (USA).
Cultivation of H. pluvialis
H. pluvialis (strain No. CCAP 34/7) was isolated by spreading 0.1 ml 
of water samples collected from Nile River phytoplankton using BG11 
media for algal isolation into Petri dishes containing 1.5% agar for 
solidification [25]. Single colonies of algae were then recultivated in the 
specified liquid media as non-axenic batch cultures (50 ml) at 25±2°C 
and 24 hrs with continuous white fluorescent lamp intensity ≈2500 
Lux. Cultivation was carried on an open pond with a capacity of 70 L 
containing 55 L of growth media. After cultivation, the biomass was 
initially separated from the water by gravitational settling and was then 
further concentrated by centrifugation, dried at 40°C and grounded 
into homogeneous fine powder.
Preparation of H. pluvialis ethanolic extract
H. pluvialis powder (100 g) was soaked in ethanol (80%) and shacked 
on shaker (Heidolph UNIMAX 2010) for 48 hrs at 150 rpm. The extract 
was filtered using a Buchner funnel and Whatman No. 4 filter paper, 
and the algal residue was reextracted with the addition of fresh ethanol 
for another 2 times. Combined filtrates were concentrated using rotary 
evaporator (Heidolph-Germany) at 40°C under vacuum to dryness. 




Male Wistar albino rats (180-200 g) procured from Central Animal 
House, National Research Centre (NRC) were used. Animals were 
acclimatized to the laboratory conditions at room temperature before 
the experimentation. Animals were kept under standard conditions 
of a 12 hrs light/dark cycle with food and water in plastic cages with 
soft bedding. The protocol was approved by the NRC Ethics Committee 
Guidelines (Approval No.: 0111457) for the use and care of animals, 
provided that the animals will not suffer at any stage of the experiment.
Drug and treatment schedule
AlCl3 solutions were made freshly at the beginning of each experiment. 
For oral administration, AlCl3 was dissolved in drinking water and 
administered in a dose of 100 mg/kg, p.o. to rats daily for 6 weeks 
0.5 ml/100 g b.wt. [27]. Donepezil drug was daily administrated for 
1 month in a dose 10 mg/kg b.wt. [28].
Animals were randomized into five groups of 10 rats each adult male 
Wistar rats based on their body weight. Each group had 10 numbers of 
animals. The groups were as follows:
• Group 1: Normal healthy untreated control rats
• Group 2: Normal control rats treated with H. pluvialis ethanolic 
extract
• Group 3: Serving as AD rats, where rats were orally administered 
with AlCl3
• Group 4: AD rats treated orally daily with H. pluvialis ethanolic extract 
for 4 weeks in a dose of 150 mg/kg b.wt. [29]
• Group 5: AD rats orally treated daily for 4 weeks with donepezil 
standard drug.
Brain tissue sampling and preparation
At the end of the experiment, the rats were fasted overnight, subjected 
to anesthesia with diethyl ether and sacrificed. The whole brain of 
each rat was rapidly dissected, washed with isotonic saline, and dried 
on filter paper. The brain was weighed and homogenized in ice-cold 
medium containing 50 mM Tris/HCl and 300 mM sucrose at pH 7.4 to 
give a 10% (w/v) homogenate [30]. This homogenate was centrifuged 
at 1400 ×g for 10 minutes at 4°C. The supernatant was stored at −80°C 
and used for biochemical analyses that included oxidative stress 
biomarker non-enzymatic glutathione (GSH) level, GSH peroxidase 
(GPx) and malondialdehyde (MDA) activity, antiapoptotic markers 
Bcl-2, and BDNF levels. The ethical conditions were applied such that 
the animals suffered no pain at any stage of the experiment, and the 
study was approved by the Ethics Committee of the NRC. Animals 
were disposed of in bags provided by the Committee of Safety and 
Environmental Health, NRC.
Biochemical analyses
Brain GSH was measured colorimetrically according to the method of 
Moron et al. [31]; GPx was determined colorimetrically according to the 
method of Ozdemir et al. [32]. Lipid peroxidation products represented 
by MDA were evaluated by the method of Satoh [33].
Brain Bcl-2 was detected by enzyme-linked immunosorbent assay 
(ELISA) technique according to the method of Barbareschi et al. [34]. 
Brain BDNF was detected by ELISA technique according to the method 
of Barakat-Walter [35].
Cytokines determination
Cytokine concentrations were measured in the brain tissues of male rats 
to monitor the baseline inflammatory scenario upon supplementation. 
Levels of tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), IL-
1β, and macrophage inflammation protein (MIP1α) were determined 
by ELISA, according to the manufacturer’s instructions (Duo Set Kit: 
Quantikine, R&D System, Minneapolis, MN, USA).
Apoptosis assay
The brain tissue (100 mg per sample) was made into single-cell 
suspensions according to method of Villalba et al. [36]. Cells apoptosis 
was determined by flow cytometry (FCM) assay using Annexin V/PI 
apoptosis detection kit. The single-cell suspension (1 × 106 cells/ml) was 
suspended in 200 µl ice-cold binding buffer, and then, 10 µl horseradish 
peroxidase fluorescein isothiocyanate (FITC) labeled Annexin V, and 5 µl 
propidium iodide (PI) was added. The cell suspension was incubated 
in darkness at room temperature for 15 minutes. Apoptosis rate was 
determined by FCM. In this study, both FITC and PI-negative cells were 
considered as normal cells. FITC-single positive and PI-negative cells 
were defined as early apoptotic cells, whereas both FITC and PI-positive 
cells were considered as late apoptotic or necrosis cells.
Gene expression analysis
Extraction of total RNA and cDNA synthesis
Brain tissues of male rats were used to extract the total RNA using 
TRIzol® Reagent (Invitrogen, Germany) kit. The isolation method was 
carried out according to the manufacturer’s instructions of the above 
kit. Approximately, 50 mg of the brain tissues were mixed with some 
drops of liquid nitrogen and homogenized in 1 ml of TRIzol® reagent in 
autoclaved mortar. Afterward, total RNA was dissolved and preserved 
in diethylpyrocarbonate-treated water up to use.
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To assess the RNA yield and purity of the total RNA, RNAse-free DNAse 
I (Invitrogen, Germany) was used to digest DNA contamination. A small 
drop of isolated RNA was examined photospectrometrically at 260 nm. 
The purity of total RNA was determined between 1.8 and 2.1 to be good 
purified when it examined by photospectrometer at the 260/280 nm 
ratio. To avoid RNA damaging, aliquots of RNA were prepared after 
isolation for either reverse transcription reaction or otherwise for 
storing at −80°C up to use.
To synthesize, the complementary DNA (cDNA) isolated RNA from 
brain tissues was reverse transcribed into cDNA. The reaction volume 
was carried out in 20 µl. The reaction volume was prepared according 
to the instructions of the RevertAidTM First Strand cDNA Synthesis Kit 
(MBI Fermentas, Germany). The reverse transcription (RT) reaction 
was performed for 10 minutes at 25°C. Afterward, the tubes of the 
reaction were put in thermocycler machine for 60 minutes at 42°C, 
and then, the reaction was terminated for 5 minutes at 99°C. The PCR 
products containing the cDNA were kept at −20°C up to use for DNA 
amplification [37,38].
Quantitative real-time PCR (qRT-PCR)
A step one real-time PCR System (Applied Biosystem, USA) was used to 
assess the copy of the cDNA of male rats to detect the expression values 
of the tested genes. To perform the PCR reaction, a volume of 25 µml of 
reaction mixtures was prepared containing 12.5 µml of SYBR® green 
(TaKaRa, Biotech Co., Ltd.), 0.5 µml of 0.2 µmM forward and reverse 
primers, 6.5 µml DNA-RNA free water, and 2.5 µml of the synthesized 
cDNA. The cDNA was propagated using reaction program consisted 
of three steps. In the first step, the PCR tubes were incubated at 95°C 
for 3 minutes. In the second step, the reaction program consisted of 
50 cycles. Each cycle of them consisted of three substeps: (a) 15 seconds 
at 95°C; (b) 30 seconds at 60°C; (c) 30 seconds at 72°C. In the third 
step, the reaction program consisted of 71 cycles. The first cycle of them 
started at 60°C for 10 seconds, and then, the followed cycles increased 
about 0.5°C every 10 seconds up to 95°C. A melting curve of the reaction 
was performed for each qRT-PCR termination at 95°C to assess the 
quality of the primers. To verify that the reaction of the qRT-PCR does 
not have any contamination PCR tubes containing non-template control 
were used. The sequences of the specific primer of the genes used are 
listed in Table 1. The relative quantification of the target genes to the 
reference (β-actin) was determined using the 2−ΔΔCT method.
Statistical analysis
Data were analyzed by one-way analysis of variance using the Statistical 
Package for the Social Sciences program, version 11 followed by least 
significant difference to compare significance between groups (p≤0.05) 
coupled with Co-state computer program, where unshared letters are 
significant at p≤0.05.
Calculations:









Effect of H. pluvialis extract on the oxidative stress biomarkers
Table 2 demonstrated an insignificant change in GSH and GPx and 
MDA levels in normal control rats treated with H. pluvialis extract 
comparing with untreated normal control rats. A significant reduction 
was detected in GSH level and GPx activity in AD rats as compared 
to normal control rats with percentages 68.48% and 64.10%, 
respectively. However, a significant increase in MDA level was noticed 
in AD-induced rats (242.10%). H. pluvialis extract-treated AD rats 
exhibited noticeable amelioration in GSH level and GPx activity with 
improvement percentages 52.46% and 29.49%, respectively. However, 
the percentages of improvement in GSH level and GPx enzyme activity 
reached to 53.48% and 42.94%, respectively, upon using donepezil 
reference drug. The data manipulated also in Table 2 indicated the 
treatment of AD rats with H. pluvialis extract significantly ameliorated 
MDA level with the percentage of improvement 154.86% comparing 
with 202.63%, for standard drug.
Indeed, most of the neurodegenerative disorders such as AD are marked 
by neuroinflammation due to increase the oxidized proteins and lipids 
as well as alteration in the free radical species in either animal or 
human [40]. The present results revealed a significant reduction in GSH 
level and GPx activity, beside the significant increase in MDA level in AD 
rats. Al has neurotoxic effect by many mechanisms such as induction 
of oxidative damage, enhancing the plaques building, and aggregation 
which induce degeneration and death of the neural cells. Oxidative 
injury in AD-induced rats is mainly attributed to weakness of the body 
defense due to decrease in the antioxidant levels which enhance the 
oxidative stress induction including high lipid peroxidation, depletion 
of brain GSH, and inhibition of GPx which may be related to increase 
H2O2 cytotoxicity in endothelial cells as a leading cause of GSH reductase 
inhibition [41,42]. It has been found that exposure to Al or its derivatives 
is able to increase the free radicals generation and decrease the activity 
level of antioxidant enzymes such as SOD, GSH, and GPx [43].
Effect of H. pluvialis extract on the brain Bcl-2 and BDNF levels
The data tabulated in Table 3 indicated an insignificant change in 
brain Bcl-2 and BDNF levels of normal control rats treated with H. 
pluvialis extract comparing with normal untreated rats. AD-induced 
rats showed a significant decrease in Bcl-2 (55.65%) and BDNF 
(46.85%) as compared to normal control rats. Remediation of AD rats 
with H. pluvialis extract showed improvement percentages in Bcl-2 
and BDNF reached to 31.11% and 31.18%, respectively, comparing 
with 46.51% and 35.87%, respectively, upon using donepezil 
standard drug.
Regarding the antiapoptotic marker, the current results showed that the 
levels of both Bcl-2 and BDNF decreased significantly in the brain of AD rats. 
The results demonstrated that BDNF could be considered as potentially 
protective signal and reenhance the antioxidant defenses of the AD rats 
to the normal case. In addition, BDNF might be considered as suppressor 
for the DNA damage and apoptosis as well as in the prevention and/or 
reversal of Alzheimer’s and other neurological diseases [43]. Moreover, 
the alteration in several biological parameters such as inflammatory 
(Nuclear factor-κB/Ikb-β) and apoptotic (Bcl-2/Bax) pathway as well 
as with the expression of pancreatic and duodenal homeobox genes in 
coinciding with the BDNF and PI3k-Akt could be competent to exhibit 
cytoprotective impact toward several toxic chemicals [43]. Aly et al. [42] 
suggested that Al as oxidative stress producer is able to disrupt the 
balance between neurotrophin and the proinflammatory cytokine 
and thus lead to induce several CNS diseases. In addition, Al decreases 
the levels of Bcl-2 and changes the ratio of Bax/Bcl-2 ratio, in which it 
plays an important role in the induction of apoptosis and generation of 
cytochrome P450 and activates the caspase-3 [27,44].
Effect of H. pluvialis extract on the cytokines level
Effect of H. pluvialis extract on the inflammatory parameters such 
as IL-6 and IL-1β, MIP1α, and TNF-α is summarized in Table 4. 
The results revealed that levels of TNF-α, IL-6, IL-1β, and MIP1α 
Table 1: Primer sequences used for qPCR
Gene Primer sequence (5ʹ–3ʹ) References




β-actin F: CAC GTG GGC CGC TCT AGG CAC CAA Khalil and Booles 
[37]
R: CTC TTT GAT GTC ACG CAC GAT TTC
F: Forward primer, R: Reverse primer, PI3K: Phosphati-dylinositol-3 kinase, 
Akt: Serine/threonine protein kinase B, qPCR: Quantitative polymerase chain 
reaction
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significantly increased in brain tissues of AD rats with percentages 
change 127.58%, 216.66%, 242.85%, and 162.80%, respectively, 
compared with those in control rats. However, the levels of the same 
parameters in brain tissues of AD rats treated with H. pluvialis extract 
decreased significantly with percentages of improvement 148.78%, 
111.49%, 183.33%, and 207.14%, respectively. In addition, the levels 
of MIP1α, TNF-α, IL-6, and IL-1β decreased significantly in AD rats 
treated with the reference drug for AD treatment, compared with 
those in AD rats.
The current results exhibited high levels of inflammation markers 
such as TNF-α, IL-6, IL-1β, and MIP1α. Therefore, the increase in the 
inflammation markers might be enhanced by increasing the levels of 
the free radicals in the brain cells. It has been reported that CNS and 
brain cells are most sensitive cells to oxidative stress because their cell 
organelles and lipid/fatty acid exposed to high oxygen concentration 
inducing free radicals and lipid peroxidation [45]. These biological 
actions explain the mechanism of neurodegenerative diseases induction 
including Alzheimer which they are markedly coincided with oxidative 
stress causing DNA damage and decrease in the protection capability of 
neural cells against endogenous oxidation [45].
In contrary, treatment of AD rats with H. pluvialis extract significantly 
decreased the levels of the inflammation markers. Several reports 
suggested that the efficiency of H. pluvialis extract in protecting the 
inflammation in brain cells is attributed to the antioxidant carotenoid 
ASTA which is existed in H. pluvialis [46]. In the same line, it has been 
found that ASTA promoted anti-inflammatory effect by inhibiting 
the mitochondrial β-oxidation and suppressing the free radicals 
generation [47].
Table 2: GSH, GPx and MDA levels in brain tissue of AD induced rats supplemented with H. pluvialis extract
Groups/parameters GSH (U/mg protein) GPX (U/mg protein) MDA (nmol/mg protein)
Normal control rats 39.06±2.20a 1.56±0.01a 7.60±0.60a
Normal control rats+H. pluvialis extract















AD rats+H. pluvialis extract























Data are means±SD of 10 rats in each group. Unshared letters between groups are the significance value at p≤0.05. SD: Standard deviation, AD: Alzheimer’s disease, 
H. pluvialis: Haematococcus pluvialis, GSH: Glutathione, GPx: Glutathione peroxidase, MDA: Malondialdehyde
Table 3: Bcl-2 and BDNF levels in brain tissue of AD induced rats supplemented with H. pluvialis extract
Groups/parameters Bcl-2 (pg/mg protein) BDNF (pg/mg protein )
Normal control rats 120.07±6.50a 90.12±7.00a
Normal control rats+H. pluvialis extract











AD rats+H. pluvialis extract

















Data are means±SD of 10 rats in each group. Unshared letters between groups are the significance value at p≤0.05. AD: Alzheimer’s disease, H. pluvialis: Haematococcus 
pluvialis, Bcl-2: B-cell lymphoma 2, BDNF: Brain derived neurotrophic factor, SD: Standard deviation
Table 4: Inflammatory cytokines level in brain tissue of AD induced rats supplemented with H. pluvialis extract
Groups/parameters TNF-α (ng/mg protein) IL-6 (ng/mg protein) IL-1β (ng/mg protein) MIP1a (ng/mg protein)
Normal control rats 17.4±6.2c 1.8±0.82c 1.4±0.51c 16.4±3.7c
Normal control rats+H. pluvialis 
extract



















AD rats+H. pluvialis extract





























Data are means±SD of 10 rats in each group. Unshared letters between groups are the significance value at p≤0.05. TNF-α: Tumor necrosis factor-alpha, IL: Interleukins 
MIP1: Macrophage inflammation protein, SD: Standard deviation
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ASTA, a red-orange carotenoid originates the red of microalgae and 
other sea organisms, exhibits antioxidant, anti-inflammatory, and 
antiapoptotic effects [48]. Recently, ASTA was observed to protect 
neurons in laboratory experiments against chronic and acute 
neurodegenerative dysfunction, neurological disorders and was 
proposed as a beneficial strategy to treat neurological diseases [49]. 
Although other antioxidants, such as resveratrol have been shown to 
protect neurons from injury in similar model systems, ASTA presents 
many advantages compared to other antioxidants displaying protective 
effects [50].
In addition, ASTA was observed to stimulate the antioxidant 
enzymes such SOD and CAT activities [51]. Moreover, other studies 
reported that ASTA was able to protect the cells toward the mutagen 
carbon tetrachloride, and consequently, inhibit the hepatic damage 
through suppression the peroxidation of the lipids and enhancing 
the antioxidants production as well as regulating the process of the 
inflammation [52].
Effect of H. pluvialis extract on the apoptosis rate
Fig. 1 showed the effect of H. pluvialis extract on the apoptosis rate in 
brain tissues of male rats with AD. The results showed that AD rats 
exhibited a high rate of apoptosis significantly compared with those 
of control group. However, the treatment of AD rats with H. pluvialis 
extract significantly decreased the rate of apoptosis compared with that 
in AD rats. Moreover, the rate of apoptosis significantly decreased in 
AD rats treated with donepezil drug compared with those in AD group.
Effect of the H. pluvialis extract on the expression of PI3K and Akt 
genes
The expression levels of the PI3K and Akt genes encoding phosphati-
dylinositol-3 kinase and serine/threonine protein kinase B, respectively, 
which play an important role in inhibiting the oxidative stress in the cells, 
were measured using quantitative real-time RT-PCR (Figs. 2 and 3). The 
results showed that AD rats exhibited lower expression significantly 
levels of PI3K and Akt genes than those in control rats. However, the 
expression levels of PI3K and Akt genes were highly expressed in AD 
rats treated with H. pluvialis extract compared with those in AD rats. 
Moreover, the PI3K and Akt genes were upregulated in AD rats treated 
with donepezil drug compared with those in AD group.
The results indicated that the expression of PI3K and Akt genes was 
downregulated which it was coincided with increase the apoptosis 
in AD rats. However, treatment of AD rats with H. pluvialis extract 
upregulated the expression of PI3K and Akt genes which consequently 
decreased the rate of apoptosis and oxidative stress of AD. In agreement 
with the current observation, ASTA was found to inhibit the apoptosis 
process, decrease the dysfunction of the mitochondria and suppress the 
production of the intracellular free radicals in the in vitro cultured [53]. 
Moreover, it has been found that ASTA supplementation improved the 
function of the mitochondria in the white blood cells of either young 
or old dogs through regulating the ATP synthesis and enhancing the 
antioxidants activity [54].
CONCLUSION
H. pluvialis could be used for AD treatment due to it decreases oxidative 
stress in the form of prevention the inflammatory and apoptotic 
impacts. The biological activity of H. pluvialis extract is might be 
regulated by ASTA which is a potent antioxidant protecting the brain 
cells from the oxidative stress in AD rats. H. pluvialis is a very attractive 
candidate against certain neurodegenerative diseases that are caused 
by oxidative stress inducing neuroinflammation and apoptosis.
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